Tanzania - English - Tanzania Medicinces & Medical Devices Authority

sterling surfactants ltd, tanzania - triclosan - liquid - 0.2

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

sterling surfactants ltd, tanzania - triclosan - liquid - 0.1

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

sterling surfactants ltd, tanzania - benzalkonium chloride - liquid - 0.1

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

sterling surfactants ltd, tanzania - ethanol - solution - 200, 500, 2000, 20000 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sterling health limited - paracetamol caffeine sodium bicarbonate -

United States - English - NLM (National Library of Medicine)

sterling-knight pharmaceuticals llc - ketoprofen (unii: 90y4qc304k) (ketoprofen - unii:90y4qc304k) - carefully consider the potential benefits and risks of ketoprofen capsules usp and other treatment options before deciding to use ketoprofen capsules usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ketoprofen capsules usp are indicated for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ketoprofen capsules usp are indicated for the management of pain. ketoprofen capsules usp are also indicated for treatment of primary dysmenorrhea. ketoprofen capsules are contraindicated in patients who have shown hypersensitivity to ketoprofen. ketoprofen capsules usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic reactions to ketoprofen have been reported in such patients (see warnings, anaphylactoid reactions andprecautions, preexisting asthma ). ketoprofen capsules are contraindicate

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sterling pest control pty ltd - 4-amino pyridine - bait - 4-amino pyridine amine/amide active 5.0 g/kg - vertebrate poison - agricultural/farm buildings | commercial area - general | domestic and/or public area | farm | industrial land or area | animal - common mynah | common starling | feral pigeon | house sparrow | tree sparrow

United States - English - NLM (National Library of Medicine)

sterling knight pharmaceuticals llc - lansoprazole (unii: 0k5c5t2qpg) (lansoprazole - unii:0k5c5t2qpg) - lansoprazole 30 mg - lansoprazole delayed-release capsules are indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer [see clinical studies (14)]. triple therapy: lansoprazole delayed-release capsules/amoxicillin/clarithromycin lansoprazole delayed-release capsules in combination with amoxicillin plus clarithromycin as triple therapy is indicated for the treatment of patients with h. pylori infection and duodenal ulcer disease (active or one-year history of a duodenal ulcer) to eradicate h. pylori. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14)]. please refer to the full prescribing information for amoxicillin and clarithromycin. dual therapy: lansoprazole delayed-release capsules/amoxicillin lansoprazole delayed-release capsules in combination with amoxicillin as dual therapy is indicated for the treatment of patients with h. pylori infection and duodenal ulcer disease (active or one-year history of a duode

United States - English - NLM (National Library of Medicine)

sterling knight pharmaceuticals,llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 300 mg - gabapentin capsules, usp are indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin capsules, usp are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy category c: there are no adequate and well-controlled studies in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic when administered to pregnant animals at doses similar to or lower than those used clinically. gabapentin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. when pregnant mice received oral doses of gabapentin (500, 1000, or 3000 mg/kg/day) during the period of organogenesis, embryo-fetal toxicity (increased incidences of skeletal variations) was observed at the two highest doses. the no-effec

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 17184 - catheter, angioplasty, balloon dilatation - the device is a monorail brand rapid exchange catheter with a semi-compliant balloon fixed at the distal tip. the balloon catheter has a coaxial shaft design. the outer lumen is used for inflation of the balloon, and the wire lumen permits the use of guidewires 0.014in or 0.018in to facilitate advancement of the catheter to and through the stenosis to be dilated. indicated for percutaneous transluminal angioplasty in the peripheral vasculature, including iliac, femoral, ilio-femoral, popliteal, renal, and carotid arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. also indicated for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature.